BACKGROUND AND PURPOSE: Oligodendrogliomas are tumors that have variable WHO grades depending on anaplasia and astrocytic components and their treatment may differ accordingly. Our aim was to retrospectively evaluate imaging features of oligodendrogliomas that predict tumor grade. MATERIALS AND METHODS: The imaging studies of 75 patients with oligodendrogliomas were retrospectively reviewed and compared with the histologic grade. The presence and degree of enhancement and calcification were evaluated subjectively. rCBV and ADC maps were measured. Logistic linear regression models were used to determine the relationship between imaging factors and tumor grade. RESULTS: Thirty of 75 (40%) tumors enhanced, including 9 of 46 (19.6%) grade II and 21 of 29 (72.4%) grade III tumors (P < .001). Grade III tumors showed lower ADC values compared with grade II tumors (odds ratio of a tumor being grade III rather than grade II = 0.07; 95% CI, 0.02-0.25; P = .001). An optimal ADC cutoff of 925 10(-6) mm(2)/s was established, which yielded a specificity of 89.1%, sensitivity of 62.1%, and accuracy of 78.7%. There was no statistically significant association between tumor grade and the presence of calcification and perfusion values. Multivariable prediction rules were applied for ADC < 925 10(-6) mm(2)/s, the presence of enhancement, and the presence of calcification. If either ADC < 925 10(-6) mm(2)/s or enhancement was present, it yielded 93.1% sensitivity, 73.9% specificity, and 81.3% accuracy. The most accurate (82.2%) predictive rule was seen when either ADC < 925 10(-6) mm(2)/s or enhancement and calcification were present. CONCLUSIONS: Models based on contrast enhancement, calcification, and ADC values can assist in predicting the grade of oligodendrogliomas and help direct biopsy sites, raise suspicion of sampling error, and predict prognosis.
BACKGROUND AND PURPOSE:Oligodendrogliomas are tumors that have variable WHO grades depending on anaplasia and astrocytic components and their treatment may differ accordingly. Our aim was to retrospectively evaluate imaging features of oligodendrogliomas that predict tumor grade. MATERIALS AND METHODS: The imaging studies of 75 patients with oligodendrogliomas were retrospectively reviewed and compared with the histologic grade. The presence and degree of enhancement and calcification were evaluated subjectively. rCBV and ADC maps were measured. Logistic linear regression models were used to determine the relationship between imaging factors and tumor grade. RESULTS: Thirty of 75 (40%) tumors enhanced, including 9 of 46 (19.6%) grade II and 21 of 29 (72.4%) grade III tumors (P < .001). Grade III tumors showed lower ADC values compared with grade II tumors (odds ratio of a tumor being grade III rather than grade II = 0.07; 95% CI, 0.02-0.25; P = .001). An optimal ADC cutoff of 925 10(-6) mm(2)/s was established, which yielded a specificity of 89.1%, sensitivity of 62.1%, and accuracy of 78.7%. There was no statistically significant association between tumor grade and the presence of calcification and perfusion values. Multivariable prediction rules were applied for ADC < 925 10(-6) mm(2)/s, the presence of enhancement, and the presence of calcification. If either ADC < 925 10(-6) mm(2)/s or enhancement was present, it yielded 93.1% sensitivity, 73.9% specificity, and 81.3% accuracy. The most accurate (82.2%) predictive rule was seen when either ADC < 925 10(-6) mm(2)/s or enhancement and calcification were present. CONCLUSIONS: Models based on contrast enhancement, calcification, and ADC values can assist in predicting the grade of oligodendrogliomas and help direct biopsy sites, raise suspicion of sampling error, and predict prognosis.
Authors: Meng Law; Sarah Oh; Glyn Johnson; James S Babb; David Zagzag; John Golfinos; Patrick J Kelly Journal: Neurosurgery Date: 2006-06 Impact factor: 4.654
Authors: Antonio C M Maia; Suzana M F Malheiros; Antonio J da Rocha; Carlos J da Silva; Alberto A Gabbai; Fernando A P Ferraz; João N Stávale Journal: AJNR Am J Neuroradiol Date: 2005-04 Impact factor: 3.825
Authors: M Vittoria Spampinato; J Keith Smith; Lester Kwock; Matthew Ewend; John D Grimme; Daniel L A Camacho; Mauricio Castillo Journal: AJR Am J Roentgenol Date: 2007-01 Impact factor: 3.959
Authors: Robert G Whitmore; Jaroslaw Krejza; Gurpreet S Kapoor; Jason Huse; John H Woo; Stephanie Bloom; Joanna Lopinto; Ronald L Wolf; Kevin Judy; Myrna R Rosenfeld; Jaclyn A Biegel; Elias R Melhem; Donald M O'Rourke Journal: J Neurosurg Date: 2007-09 Impact factor: 5.115
Authors: David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues Journal: Acta Neuropathol Date: 2007-07-06 Impact factor: 17.088
Authors: Valeria Cuccarini; A Erbetta; M Farinotti; L Cuppini; F Ghielmetti; B Pollo; F Di Meco; M Grisoli; G Filippini; G Finocchiaro; M G Bruzzone; M Eoli Journal: J Neurooncol Date: 2016-01 Impact factor: 4.130
Authors: Fred H Hochberg; Nadia A Atai; David Gonda; Michael S Hughes; Brolin Mawejje; Leonora Balaj; Robert S Carter Journal: Expert Rev Mol Diagn Date: 2014-05 Impact factor: 5.225
Authors: Thomas Hundsberger; Michaela Tonder; Andreas Hottinger; Detlef Brügge; Ulrich Roelcke; Paul Martin Putora; Roger Stupp; Michael Weller Journal: J Neurooncol Date: 2014-04-16 Impact factor: 4.130
Authors: Julio Arevalo-Perez; Amanuel A Kebede; Kyung K Peck; Eli Diamond; Andrei I Holodny; Marc Rosenblum; Jennifer Rubel; Joshua Gaal; Vaios Hatzoglou Journal: J Neuroimaging Date: 2015-12-26 Impact factor: 2.486
Authors: Anna Falk; Markus Fahlström; Egill Rostrup; Shala Berntsson; Maria Zetterling; Arvid Morell; Henrik B W Larsson; Anja Smits; Elna-Marie Larsson Journal: Neuroradiology Date: 2014-09-10 Impact factor: 2.804
Authors: Roberto José-López; Rodrigo Gutierrez-Quintana; Cristian de la Fuente; Edgar G Manzanilla; Anna Suñol; Dolors Pi Castro; Sonia Añor; Daniel Sánchez-Masian; Francisco Fernández-Flores; Emanuele Ricci; Katia Marioni-Henry; Joan Mascort; Lara A Matiasek; Kaspar Matiasek; Paul M Brennan; Martí Pumarola Journal: J Vet Intern Med Date: 2021-06-12 Impact factor: 3.175